Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

prostate cancer, hereditary, 12 - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

prostate cancer, hereditary, 12

MONDO:0012741

Also known as:EHBP1 familial prostate cancerfamilial prostate cancer caused by mutation in EHBP1prostate cancer, hereditary, type 12

Overview

Any familial prostate cancer in which the cause of the disease is a mutation in the EHBP1 gene.

ResearchLimited published research (7 articles)

Diagnosis

Biomarker and diagnostic research for prostate cancer, hereditary, 12 has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for prostate cancer, hereditary, 12.

7 publications have been identified in PubMed for prostate cancer, hereditary, 12. Research spans Diagnostic / Biomarker (57%), Epidemiology / Natural History (29%), and Clinical Trial Publication (14%).

Recent Publications

Kiljańczyk M (2026). [PMID: 42265275](https://pubmed.ncbi.nlm.nih.gov/42265275/). *Eur J Hum Genet*. [Epidemiology / Natural History]
Graham LS (2026). [PMID: 42207997](https://pubmed.ncbi.nlm.nih.gov/42207997/). *JCO Oncol Pract*. [Diagnostic / Biomarker]
Godiveau M (2025). [PMID: 39926282](https://pubmed.ncbi.nlm.nih.gov/39926282/). *Frontiers in oncology*. [Epidemiology / Natural History]
Flores-Lagunes LL (2025). [PMID: 40960710](https://pubmed.ncbi.nlm.nih.gov/40960710/). *Familial cancer*. [Diagnostic / Biomarker]
Shore N (2025). [PMID: 39700441](https://pubmed.ncbi.nlm.nih.gov/39700441/). *JCO oncology practice*. [Diagnostic / Biomarker]

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:49 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

OMIM

Online Mendelian Inheritance in Man

OMIM:611868

GARD

Genetic and Rare Diseases Info Center

GARD:15529

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

prostate cancer, hereditary, 12

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team